Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Prospective, Randomized, Investigator-Blind, Controlled, Clinical Study of Phase III on the Efficacy and Tolerability of hMG-IBSA (IBSA) Vs Menopure (Ferring) Administered s.c. [subcutaneously] in Women Undergoing COH [controlled ovarian hyperstimulation] in an ART Programme (IVF) [in vitro fertilisation]

Trial Profile

A Prospective, Randomized, Investigator-Blind, Controlled, Clinical Study of Phase III on the Efficacy and Tolerability of hMG-IBSA (IBSA) Vs Menopure (Ferring) Administered s.c. [subcutaneously] in Women Undergoing COH [controlled ovarian hyperstimulation] in an ART Programme (IVF) [in vitro fertilisation]

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 03 Nov 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Menotropin (Primary)
  • Indications Infertility
  • Focus Therapeutic Use
  • Acronyms ART-Programme
  • Sponsors IBSA
  • Most Recent Events

    • 17 Dec 2008 Actual end date (May 2008) added as reported by ClinicalTrials.gov.
    • 17 Dec 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 08 Oct 2006 New trial record.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with a username/password associated to your organization’s account.
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Federated access using single sign-on credentials.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top